These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1387755

  • 1. Thyroid hormones and atrial natriuretic hormone secretion: study in hyper- and hypothyroid patients.
    Rolandi E, Santaniello B, Bagnasco M, Cataldi A, Garibaldi C, Franceschini R, Barreca T.
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):23-6. PubMed ID: 1387755
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum angiotensin-converting enzyme and plasma atrial natriuretic peptide levels in hyperthyroid and hypothyroid rabbits.
    Yeğin E, Yiğitoğlu R, Ari Z, Celik I, Akçay F, Süzek H.
    Jpn Heart J; 1997 Mar; 38(2):273-9. PubMed ID: 9201114
    [Abstract] [Full Text] [Related]

  • 4. Plasma atriopeptin concentrations in hyperthyroidism, euthyroidism, and hypothyroidism: studies in man and rat.
    Ladenson PW, Langevin H, Michener M.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1172-6. PubMed ID: 2960689
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma atrial natriuretic hormone in hyperthyroidism.
    Parlapiano C, Campana E, Alessandri N, Rota C, Sellini M, Vecci E, Tonnarini G, Borgia MC, Negri M.
    Endocr Res; 1998 Feb; 24(1):105-12. PubMed ID: 9553758
    [Abstract] [Full Text] [Related]

  • 7. Prohormone atrial natriuretic peptides 1-30 and 31-67 increase in hyperthyroidism and decrease in hypothyroidism.
    Vesely DL, Winters CJ, Sallman AL.
    Am J Med Sci; 1989 Apr; 297(4):209-15. PubMed ID: 2523193
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease.
    Shigematsu S, Iwasaki T, Aizawa T, Ishihara M, Shinoda T, Yamada T, Sato A, Takemura Y.
    Horm Metab Res; 1989 Sep; 21(9):514-8. PubMed ID: 2531114
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.
    Ozkaya M, Sahin M, Cakal E, Yuzbasioglu F, Sezer K, Kilinc M, Imrek SS.
    J Endocrinol Invest; 2009 May; 32(5):435-9. PubMed ID: 19498324
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment.
    Ahrén B, Lundquist I, Hedner P, Valdemarsson S, Scherstén B.
    Diabetes Res; 1985 Mar; 2(2):95-103. PubMed ID: 2412749
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.